NCT04927156

Brief Summary

BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices. This platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
187mo left

Started Jul 2021

Longer than P75 for all trials

Geographic Reach
3 countries

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Jul 2021Oct 2041

First Submitted

Initial submission to the registry

June 9, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 15, 2021

Completed
27 days until next milestone

Study Start

First participant enrolled

July 12, 2021

Completed
19.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2041

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2041

Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

19.9 years

First QC Date

June 9, 2021

Last Update Submit

September 16, 2025

Conditions

Keywords

catheterguidewire

Outcome Measures

Primary Outcomes (4)

  • Rate of occurrence of device-specific safety indicator(s).

    Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    From the procedure to 12 months post-procedure depending on the device family.

  • Rate of devices achieving its intended use.

    Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    From the procedure to 12 months post-procedure depending on the device family.

  • Rate of devices achieving its specific performance indicator(s).

    Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    From the procedure to 12 months post-procedure depending on the device family.

  • Rate of devices in each category of the usability scale (Likert-type scale) for each usability indicator

    Qualitative measurement of usability for each usability indicator (i.e., good, well adapted, fairly adapted, bad). Specific outcomes will be adapted accordingly for each device family since the intended use will vary according to the device families.

    From the procedure to 12 months post-procedure depending on the device family.

Study Arms (1)

BALT medical devices

Device: BALT medical devices

Interventions

Includes, but is not limited to, the following: * Access devices * Aneurysm treatment devices * Ischemic Stroke and peripheral occlusive diseases treatment devices * Arterio-Venous Malformations/fistulas treatment devices

BALT medical devices

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will include the BALT medical devices under consideration used in their respective indications for use during interventions performed at the participating sites.

You may qualify if:

  • Provision of a signed, written and dated informed consent or non-opposition (where applicable)

You may not qualify if:

  • Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)
  • Contra-indications of each device as described in the instructions for use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

CHU Angers

Angers, France

RECRUITING

Chu Bordeaux

Bordeaux, France

RECRUITING

CHU Grenoble Alpes

La Tronche, France

RECRUITING

Hôpital Roger Salengro

Lille, France

RECRUITING

Kremlin Bicêtre - APHP

Paris, France

RECRUITING

Chu Tours

Tours, 37000, France

RECRUITING

Halle

Halle, Germany

RECRUITING

Hospital: Fundacion Jimenez Diaz

Madrid, 28222, Spain

RECRUITING

Hospital Clinico Universitario San Carlos

Madrid, Spain

TERMINATED

Unversitario Central de Asturias

Oviedo, 33011, Spain

RECRUITING

Hospital Universitario Marqués de Valdecilla (HUMV)

Santander, Spain

RECRUITING

Hospital Universitario Miguel Servet

Zaragoza, Spain

NOT YET RECRUITING

Related Links

MeSH Terms

Conditions

Intracranial AneurysmIntracranial Arterial DiseasesIschemic StrokePeripheral Vascular DiseasesIntracranial Arteriovenous MalformationsArteriovenous Fistula

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular DiseasesStrokeCentral Nervous System Vascular MalformationsNervous System MalformationsArteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesVascular FistulaFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Clinical Affairs Department

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2021

First Posted

June 15, 2021

Study Start

July 12, 2021

Primary Completion (Estimated)

June 1, 2041

Study Completion (Estimated)

October 1, 2041

Last Updated

September 18, 2025

Record last verified: 2025-09

Locations